Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma
Open Access
- 30 October 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (11), 3661-3669
- https://doi.org/10.1002/art.22179
Abstract
Objective To investigate the potential association between functional polymorphisms in the gene for the innate mediator, macrophage migration inhibitory factor (MIF), and the clinical expression of systemic sclerosis (SSc). Methods Genomic DNA samples and clinical data were collected from the Scleroderma Family Registry and DNA Repository at the University of Texas Health Science Center at Houston. A total of 740 subjects were studied; 203 of them had diffuse cutaneous SSc (dcSSc), 283 had limited cutaneous SSc (lcSSc), and the remaining 254 healthy subjects served as controls. Association analyses were performed on the whole data set and on patient and sex subsets. Significant relationships were determined between clinical variables and MIF polymorphisms for each disease subtype in the studied groups. Results The frequency of the −173*C MIF allele, which was previously reported to be associated with high production of MIF, was lower in the lcSSc group (12.6%) than in the dcSSc (19.2%) or control (18.5%) groups (P = 0.010 and P = 0.011, respectively). Haplotype analysis for 2 closely linked polymorphisms in the MIF promoter showed that in white subjects with lcSSc or dcSSc, the lcSSc population had a significantly lower representation of the high-expression MIF haplotype defined by −173*C and −794 with 7 CATT repeats (C7) (P = 0.015, odds ratio 1.94 [95% confidence interval 1.14–3.32]). Fibroblasts encoding the C7 MIF haplotype were observed to produce more MIF upon in vitro stimulation than those with a non-C7 haplotype. Conclusion Functional promoter polymorphisms in the MIF gene affect the clinical presentation of SSc. The proinflammatory haplotype defined by C7 is underrepresented in patients with lcSSc.Keywords
This publication has 46 references indexed in Scilit:
- Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factorArthritis & Rheumatism, 2005
- Association of the -173?G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitisThe Esophagus, 2004
- The TNF‐863A allele strongly associates with anticentromere antibody positivity in sclerodermaArthritis & Rheumatism, 2004
- Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphismsBiostatistics, 2003
- Macrophage migration inhibitory factor: a regulator of innate immunityNature Reviews Immunology, 2003
- Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: Incorporating disease outcome into the definition of phenotypeArthritis & Rheumatism, 2003
- Expression of macrophage migration inhibitory factor in diffuse systemic sclerosisAnnals Of The Rheumatic Diseases, 2003
- Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to CutaneousLeishmania majorInfectionInfection and Immunity, 2001
- HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodiesHuman Immunology, 1995
- Purification, Bioactivity, and Secondary Structure Analysis of Mouse and Human Macrophage Migration Inhibitory Factor (MIF)Biochemistry, 1994